Gain Therapeutics logo

Gain Therapeutics Share Price Today

(NASDAQ: GANX)

Gain Therapeutics share price is $2.41 & ₹209.24 as on 12 Feb 2025, 20.17 hrs IST

$2.41

-0.1

(-3.98%)

Market is closed - opens 8 PM, 12 Feb 2025

View live Gain Therapeutics share price in Dollar and Rupees. Guide to invest in Gain Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Gain Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Gain Therapeutics share price movements

  • Today's Low: $2.39
    Today's High: $2.56

    Day's Volatility :6.65%

  • 52 Weeks Low: $0.89
    52 Weeks High: $5.19

    52 Weeks Volatility :82.85%

Gain Therapeutics (GANX) Returns

PeriodGain Therapeutics IncIndex (Russel 2000)
3 Months
18.72%
0.0%
6 Months
115.18%
0.0%
1 Year
-46.56%
0.0%
3 Years
-42.07%
-12.9%

Gain Therapeutics (GANX) Key Statistics

in dollars & INR

Previous Close
$2.41
Open
$2.52
Today's High
$2.4
Today's Low
$2.33
Market Capitalization
$66.6M
Today's Volume
$126.6K
52 Week High
$5.19
52 Week Low
$0.89
Revenue TTM
$0.0
EBITDA
$-21.8M
Earnings Per Share (EPS)
$-1.03
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-188.83%

How to invest in Gain Therapeutics Stock (GANX) from India?

It is very easy for Indian residents to invest directly in Gain Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Gain Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Gain Therapeutics or GANX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Gain Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Gain Therapeutics shares which would translate to 0.360 fractional shares of Gain Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Gain Therapeutics, in just a few clicks!

Returns in Gain Therapeutics (GANX) for Indian investors in Rupees

The Gain Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gain Therapeutics investment value today

Current value as on today

₹58,026

Returns

₹41,974

(-41.97%)

Returns from Gain Therapeutics Stock

₹46,563 (-46.56%)

Dollar Returns

₹4,590 (+4.59%)

Indian investors sentiment towards Gain Therapeutics (GANX)

-50%

Period: Jan 12, 2025 to Feb 11, 2025. Change in 30 Days versus previous period

Search interest for Gain Therapeutics Stock from India on INDmoney has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Gain Therapeutics

  • Gotham Asset Management, LLC

    1.26%

  • Geode Capital Management, LLC

    1.03%

  • Vanguard Group Inc

    0.55%

  • BlackRock Inc

    0.32%

  • JONES FINANCIAL COMPANIES LLLP

    0.20%

  • Renaissance Technologies Corp

    0.20%

Analyst Recommendation on Gain Therapeutics

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Gain Therapeutics(by analysts ranked 0 to 5 stars)

Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
10
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Gain Therapeutics Stock (GANX)

What analysts predicted

Upside of 204.29%

Target:

$7.33

Current:

$2.41

Insights on Gain Therapeutics Stock (Ticker Symbol: GANX)

  • Price Movement

    In the last 6 months, GANX stock has moved up by 156.8%
  • GANX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.8% return, outperforming this stock by 108.4%
  • GANX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 78.4% return, outperforming this stock by 120.3%

Gain Therapeutics Technicals Summary

Sell

Neutral

Buy

Gain Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Gain Therapeutics (GANX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Gain Therapeutics Inc logo
10.05%
115.18%
-46.56%
-42.07%
-78.48%
Biontech Se logo
0.67%
34.94%
26.41%
-25.9%
272.36%
Regeneron Pharmaceuticals, Inc. logo
-7.18%
-42.48%
-29.24%
6.72%
66.55%
Vertex Pharmaceuticals Incorporated logo
10.12%
-3.44%
9.42%
96.87%
86.7%
Alnylam Pharmaceuticals, Inc. logo
4.15%
2.32%
66.04%
80.94%
109.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Gain Therapeutics Inc logo
NA
NA
NA
-0.98
-1.89
-0.73
NA
0.78
Biontech Se logo
160.8
NA
0.04
-3.29
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
18.52
18.52
1.04
43.84
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.23
18.76
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Gain Therapeutics Inc logo
Buy
$66.6M
-78.48%
NA
0.0%
Biontech Se logo
Buy
$27.6B
272.36%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$75.5B
66.55%
18.52
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$121.0B
86.7%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.3B
109.01%
NA
-15.86%

About Gain Therapeutics

Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease. The company's lead drug candidate, GT-02287 for the treatment of GBA1 Parkinson's disease is being evaluated in a Phase I clinical trials. It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of Dementia with Lewy Bodies, Alzhiemer's Disease, Gaucher, GM1 Gangliosidosis, Krabbe Disease, Alpha1-Antitrypsun deficiency, and solid tumors. The company was founded in 2017 and is headquartered in Bethesda, Maryland.
Organization
Gain Therapeutics
Employees
29
CEO
Mr. Gene Mack M.B.A.
Industry
Miscellaneous

Management People of Gain Therapeutics

NameTitle
Dr. Khalid Islam Ph.D.
Executive Chairman
Mr. Gene Mack M.B.A.
CFO & Interim CEO
Dr. Joanne Taylor Ph.D.
Senior Vice President of Research
Dr. Terenzio Ignoni Pharm.D.
Senior Vice President of Technical Operations
Dr. Jonas Hannestad M.D., Ph.D.
Chief Medical Officer

Important FAQs about investing in GANX Stock from India :

What is Gain Therapeutics share price today?

Gain Therapeutics share price today stands at $2.41, Open: $2.52 ; Previous Close: $2.51 ; High: $2.56 ; Low: $2.39 ; 52 Week High: $5.19 ; 52 Week Low: $0.89.

The stock opens at $2.52, after a previous close of $2.51. The stock reached a daily high of $2.56 and a low of $2.39, with a 52-week high of $5.19 and a 52-week low of $0.89.

Can Indians buy Gain Therapeutics shares?

Yes, Indians can invest in the Gain Therapeutics (GANX) from India.

With INDmoney, you can buy Gain Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Gain Therapeutics at zero transaction cost.

How can I buy Gain Therapeutics shares from India?

It is very easy to buy Gain Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Gain Therapeutics (GANX) be purchased?

Yes, you can buy fractional shares of Gain Therapeutics with INDmoney app.

What are the documents required to start investing in Gain Therapeutics stocks?

To start investing in Gain Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Gain Therapeutics Stock (GANX)?

Today’s highest price of Gain Therapeutics (GANX) is $2.56.

Today’s lowest price of Gain Therapeutics (GANX) is $2.39.

What is today's market capitalisation of Gain Therapeutics?

Today's market capitalisation of Gain Therapeutics GANX is 66.6M

What is the 52 Week High and Low Range of Gain Therapeutics Stock (GANX)?

  • 52 Week High

    $5.19

  • 52 Week Low

    $0.89

What are the historical returns of Gain Therapeutics (GANX)?

  • 1 Month Returns

    10.05%

  • 3 Months Returns

    115.18%

  • 1 Year Returns

    -46.56%

  • 5 Years Returns

    -78.48%

Who is the Chief Executive Officer (CEO) of Gain Therapeutics ?

Mr. Gene Mack M.B.A. is the current Chief Executive Officer (CEO) of Gain Therapeutics.